• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人造血祖细胞的细胞介导裂解

Cell-mediated lysis of human hematopoietic progenitor cells.

作者信息

Voogt P J, Fibbe W E, Veenhof W F, Brand A, Goulmy E, van Rood J J, Falkenburg J H

机构信息

Laboratory of Experimental Hematology, University Medical Center, Leiden, The Netherlands.

出版信息

Leukemia. 1987 May;1(5):427-31.

PMID:3499546
Abstract

Several techniques are available for the serological analysis of antigenic determinants on human hematopoietic progenitor cells (HPC). However, techniques for the recognition of cellularly defined antigens on such progenitor cells have not yet been described. We therefore developed an in vitro cellular cytotoxicity assay, with bone marrow cells as target cells. In this assay specific cytotoxic T lymphocyte (CTL) lines are used as effectors for cell-mediated cytolysis of bone marrow mononuclear cells that express the antigens for which the CTLs were primed in a mixed lymphocyte culture. As a model we used CTL lines against HLA-A2 or -B7 determinants. By using effector-target ratios varying from 1:2 to 4:1, 4 hr of incubation of these CTL lines with bone marrow mononuclear cells from HLA-A2 or -B7 positive donors resulted in a specific dose-dependent growth inhibition up to 100% of myeloid (CFU-GM), erythroid (BFU-E), and multipotential (CFU-GEMM) HPC. In contrast no inhibition of HPC was observed using mononuclear bone marrow cells from HLA-A2 or -B7 negative individuals as target cells. Experiments in which cell-cell contact was prevented showed that the antigen-specific lysis of HPC was dependent on intimate cell-cell contact between effector-CTLs and bone marrow target cells. Our results show that this cell-mediated cytotoxicity assay can be used as a sensitive and specific tool for the study of cellularly defined antigens on human hematopoietic progenitor cells.

摘要

有几种技术可用于对人类造血祖细胞(HPC)上的抗原决定簇进行血清学分析。然而,尚未描述用于识别此类祖细胞上细胞定义抗原的技术。因此,我们开发了一种以骨髓细胞为靶细胞的体外细胞毒性测定法。在该测定法中,特异性细胞毒性T淋巴细胞(CTL)系用作效应细胞,用于对表达抗原的骨髓单个核细胞进行细胞介导的细胞溶解,这些抗原是CTL在混合淋巴细胞培养中被致敏的对象。作为模型,我们使用了针对HLA - A2或 - B7决定簇的CTL系。通过使用从1:2到4:1变化的效应细胞与靶细胞比例,将这些CTL系与来自HLA - A2或 - B7阳性供体的骨髓单个核细胞孵育4小时,导致髓系(CFU - GM)、红系(BFU - E)和多能(CFU - GEMM)HPC出现特异性剂量依赖性生长抑制,最高可达100%。相比之下,使用来自HLA - A2或 - B7阴性个体的骨髓单个核细胞作为靶细胞时,未观察到HPC受到抑制。防止细胞 - 细胞接触的实验表明,HPC的抗原特异性裂解依赖于效应CTL与骨髓靶细胞之间紧密的细胞 - 细胞接触。我们的结果表明,这种细胞介导的细胞毒性测定法可作为研究人类造血祖细胞上细胞定义抗原的灵敏且特异的工具。

相似文献

1
Cell-mediated lysis of human hematopoietic progenitor cells.人造血祖细胞的细胞介导裂解
Leukemia. 1987 May;1(5):427-31.
2
Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.正常造血祖细胞和恶性淋巴造血细胞对T细胞受体 - /CD3 - 、T细胞受体γδ + /CD3 + 和T细胞受体αβ + /CD3 + 淋巴细胞介导的直接细胞介导的MHC非限制性裂解表现出不同的敏感性。
J Immunol. 1989 Mar 1;142(5):1774-80.
3
Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.次要组织相容性抗原H-Y在人类造血祖细胞上表达。
J Clin Invest. 1988 Sep;82(3):906-12. doi: 10.1172/JCI113697.
4
Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.通过CD8 +或CD4 +次要组织相容性抗原特异性细胞毒性T淋巴细胞识别克隆性白血病细胞、缓解期骨髓和HLA匹配供体骨髓。
J Clin Invest. 1995 Aug;96(2):877-83. doi: 10.1172/JCI118134.
5
Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.次要组织相容性抗原HA-1、-2和-4以及HY特异性细胞毒性T细胞克隆通过一种依赖直接细胞间接触的机制抑制人类造血祖细胞的生长。
Blood. 1993 Dec 15;82(12):3778-85.
6
The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.人类肿瘤坏死因子对正常供体及白血病患者骨髓造血祖细胞的抑制作用:肿瘤坏死因子与γ干扰素的协同作用
J Immunol. 1986 Jun 15;136(12):4487-95.
7
Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.用My10和主要组织相容性复合体II类单克隆抗体通过双色细胞分选高度富集的成人人类骨髓造血祖细胞的特征分析
J Immunol. 1987 Sep 15;139(6):1823-9.
8
Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.人类造血祖细胞亚群中II类主要组织相容性复合体抗原的差异表达。
Leukemia. 1988 Oct;2(10):677-86.
9
[Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].利用特异性靶向WT1衍生肽的细胞毒性T淋巴细胞消除白血病CD34 +祖细胞:体外实验研究
Zhonghua Yi Xue Za Zhi. 2008 Dec 30;88(48):3401-6.
10
Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.由特异性鼠细胞毒性T细胞克隆所定义的表达HLA - B7的人和鼠细胞上的多个表位。
J Immunol. 1985 Aug;135(2):900-5.

引用本文的文献

1
Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.通过CD8 +或CD4 +次要组织相容性抗原特异性细胞毒性T淋巴细胞识别克隆性白血病细胞、缓解期骨髓和HLA匹配供体骨髓。
J Clin Invest. 1995 Aug;96(2):877-83. doi: 10.1172/JCI118134.
2
Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.次要组织相容性抗原H-Y在人类造血祖细胞上表达。
J Clin Invest. 1988 Sep;82(3):906-12. doi: 10.1172/JCI113697.
3
Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells.
细胞定义的次要组织相容性抗原在人类造血祖细胞上存在差异表达。
J Exp Med. 1988 Dec 1;168(6):2337-47. doi: 10.1084/jem.168.6.2337.